Valuation: Bachem Holding AG

Market Cap 6.32B 7.65B 6.85B 5.72B 10.7B 728B 10.87B 75.41B 30.08B 381B 28.71B 28.1B 1,207B P/E 2026 *
34.6x
P/E 2027 * 27.1x
Enterprise Value 6.68B 8.09B 7.25B 6.05B 11.31B 770B 11.49B 79.75B 31.81B 403B 30.36B 29.71B 1,277B EV / Sales 2026 *
7.08x
EV / Sales 2027 * 5.97x
Free-Float
99.67%
Yield 2026 *
1.2%
Yield 2027 * 1.35%
1 day-0.41%
1 week+1.57%
Current month+3.82%
1 month+3.82%
3 months+9.29%
6 months+18.86%
Current year+40.48%
1 week 81.85
Extreme 81.85
85.9
1 month 77.65
Extreme 77.65
86
Current year 53.95
Extreme 53.95
86
1 year 48.52
Extreme 48.52
86
3 years 43.34
Extreme 43.34
91.65
5 years 43.34
Extreme 43.34
151.6
10 years 15.96
Extreme 15.96
171
Manager TitleAgeSince
Chief Executive Officer 52 2025-12-31
Director of Finance/CFO 49 2021-01-31
Chief Operating Officer - 2025-08-31
Director TitleAgeSince
Chairman 70 2012-04-24
Director/Board Member 53 2011-04-12
Director/Board Member 57 2014-04-27
Date Insider Type Main position Quantity % Market Cap. Importance
5/8/26 Sell -1,373 0.0018%
3/18/26 Buy 248 0.0003%
10/16/25 Sell 1,000 0.0013%
Change 5-day change 1-year change 3-year change Capi.($)
-0.41%+1.57%+43.23%+31.90% 7.65B
+0.34%+1.12%+34.75%+61.06% 64.38B
+0.85%+3.78%+15.58%+85.60% 56.16B
+0.81%+2.50%+15.97%+107.90% 54.16B
-1.28%-2.74%+25.51%+53.36% 45.33B
+0.41%-1.09%+21.19%+100.17% 42.25B
-0.98%+0.59%+219.51%+925.04% 40.78B
+2.36%+46.79%+110.98%+94.93% 33.8B
-0.26%-2.57%+12.55%+45.18% 32.25B
-1.29%-2.88%+21.60%-11.92% 23.57B
Average +0.06%+4.27%+52.09%+149.32% 40.03B
Weighted average by Cap. +0.18%+3.57%+49.90%+158.84%

Financials

2026 *2027 *
Net sales 944M 1.14B 1.02B 854M 1.6B 109B 1.62B 11.26B 4.49B 56.94B 4.29B 4.2B 180B 1.16B 1.41B 1.26B 1.05B 1.97B 134B 2B 13.87B 5.53B 70.09B 5.28B 5.17B 222B
Net income 182M 220M 197M 165M 308M 20.96B 313M 2.17B 865M 10.97B 826M 808M 34.74B 229M 277M 248M 207M 388M 26.41B 394M 2.73B 1.09B 13.82B 1.04B 1.02B 43.77B
Net Debt 364M 440M 394M 329M 615M 41.9B 625M 4.34B 1.73B 21.93B 1.65B 1.62B 69.45B 622M 753M 674M 563M 1.05B 71.67B 1.07B 7.42B 2.96B 37.51B 2.82B 2.76B 119B
Projected Income Statement - Annual - Bachem Holding AG
Logo Bachem Holding AG
Bachem Holding AG is a Switzerland-based biochemical company that provides services to the pharmaceutical and biotechnology industry. The Company focuses on the process development and manufacturing of peptides and organic molecules as active pharmaceutical ingredients (APIs), as well as on the development of biochemical products for research purposes. Its product portfolio comprises fluorescent dyes for the fluorescence energy transfer (FRET) analysis of receptor-ligand interactions, protein-protein interactions and the cleavage of substrate molecules, as well as glycosylated peptides for the manipulation of drug properties. The Company markets products under the Bachem and Clinalfa brands and operates production facilities in Switzerland and in the United States.
Employees
2,725
Date Price Change Volume
26-10-30 CHF 84.25 -0.12% 19,400
26-10-29 CHF 84.35 +0.36% 68,611
26-10-28 CHF 84.05 +0.84% 59,510
26-10-27 CHF 83.35 +0.60% 42,244
26-10-26 CHF 82.85 0.00% 59,462
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Bachem Holding AG
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
84.35CHF
Average target price
84.30CHF
Spread / Average Target
-0.06%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Bachem Holding AG
  1. Stock Market
  2. Stocks
  3. BANB Stock